126 related articles for article (PubMed ID: 30096576)
1. The clinical significance of CDX2 in leukemia: A new perspective for leukemia research.
Darvishi M; Mashati P; Khosravi A
Leuk Res; 2018 Sep; 72():45-51. PubMed ID: 30096576
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.
Riedt T; Ebinger M; Salih HR; Tomiuk J; Handgretinger R; Kanz L; Grünebach F; Lengerke C
Blood; 2009 Apr; 113(17):4049-51. PubMed ID: 19218548
[TBL] [Abstract][Full Text] [Related]
3. The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia.
Thoene S; Rawat VP; Heilmeier B; Hoster E; Metzeler KH; Herold T; Hiddemann W; Gökbuget N; Hoelzer D; Bohlander SK; Feuring-Buske M; Buske C
Leukemia; 2009 Apr; 23(4):649-55. PubMed ID: 19158837
[TBL] [Abstract][Full Text] [Related]
4. Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
Niemann CU; Kjeldsen L; Ralfkiaer E; Jensen MK; Borregaard N
Leukemia; 2007 Dec; 21(12):2406-10. PubMed ID: 17928883
[TBL] [Abstract][Full Text] [Related]
5. CDX2 gene expression in acute lymphoblastic leukemia.
Arnaoaut HH; Mokhtar DA; Samy RM; Khames SA; Omar SA
J Egypt Natl Canc Inst; 2014 Jun; 26(2):55-9. PubMed ID: 24841154
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.
Vu T; Straube J; Porter AH; Bywater M; Song A; Ling V; Cooper L; Pali G; Bruedigam C; Jacquelin S; Green J; Magor G; Perkins A; Chalk AM; Walkley CR; Heidel FH; Mukhopadhyay P; Cloonan N; Gröschel S; Mallm JP; Fröhling S; Scholl C; Lane SW
Nat Commun; 2020 Jun; 11(1):3021. PubMed ID: 32541670
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA and Acute Leukemia.
Cruz-Miranda GM; Hidalgo-Miranda A; Bárcenas-López DA; Núñez-Enríquez JC; Ramírez-Bello J; Mejía-Aranguré JM; Jiménez-Morales S
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744139
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
[TBL] [Abstract][Full Text] [Related]
9. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
10. Role of HOTAIR in the diagnosis and prognosis of acute leukemia.
Zhang YY; Huang SH; Zhou HR; Chen CJ; Tian LH; Shen JZ
Oncol Rep; 2016 Dec; 36(6):3113-3122. PubMed ID: 27748863
[TBL] [Abstract][Full Text] [Related]
11. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.
Rawat VP; Thoene S; Naidu VM; Arseni N; Heilmeier B; Metzeler K; Petropoulos K; Deshpande A; Quintanilla-Martinez L; Bohlander SK; Spiekermann K; Hiddemann W; Feuring-Buske M; Buske C
Blood; 2008 Jan; 111(1):309-19. PubMed ID: 17855634
[TBL] [Abstract][Full Text] [Related]
13. ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia.
Abraham A; Karathedath S; Varatharajan S; Markose P; Chendamarai E; Jayavelu AK; George B; Srivastava A; Mathews V; Balasubramanian P
Ann Hematol; 2014 Mar; 93(3):509-12. PubMed ID: 23793916
[No Abstract] [Full Text] [Related]
14. [MicroRNA-s and their role in malignant hematologic diseases].
Gaál Z; Oláh E
Orv Hetil; 2012 Dec; 153(52):2051-9. PubMed ID: 23261993
[TBL] [Abstract][Full Text] [Related]
15. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
Faber K; Bullinger L; Ragu C; Garding A; Mertens D; Miller C; Martin D; Walcher D; Döhner K; Döhner H; Claus R; Plass C; Sykes SM; Lane SW; Scholl C; Fröhling S
J Clin Invest; 2013 Jan; 123(1):299-314. PubMed ID: 23202735
[TBL] [Abstract][Full Text] [Related]
16. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
[TBL] [Abstract][Full Text] [Related]
17. Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients.
Radwan SM; Hamdy NM; Hegab HM; El-Mesallamy HO
Cancer Biomark; 2016 Mar; 16(4):619-26. PubMed ID: 27002764
[TBL] [Abstract][Full Text] [Related]
18. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Passet M; Kim R; Gachet S; Sigaux F; Chaumeil J; Galland A; Sexton T; Quentin S; Hernandez L; Larcher L; Bergugnat H; Ye T; Karasu N; Caye A; Heizmann B; Duluc I; Chevallier P; Rousselot P; Huguet F; Leguay T; Hunault M; Pflumio F; Freund JN; Lobry C; Lhéritier V; Dombret H; Domon-Dell C; Soulier J; Boissel N; Clappier E
Blood; 2022 Jun; 139(24):3505-3518. PubMed ID: 35316324
[TBL] [Abstract][Full Text] [Related]
19. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology strategies to detect residual disease.
Garcés-Eisele J
Hematology; 2012 Apr; 17 Suppl 1():S66-8. PubMed ID: 22507783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
